KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 108 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 4.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $214,422 | +50.1% | 22,266 | +40.3% | 0.00% | – |
Q2 2023 | $142,821 | +169.4% | 15,869 | +135.2% | 0.00% | – |
Q1 2023 | $53,023 | -18.6% | 6,746 | -30.0% | 0.00% | – |
Q4 2022 | $65,126 | +261.8% | 9,634 | +682.0% | 0.00% | – |
Q3 2022 | $18,000 | +80.0% | 1,232 | +15.8% | 0.00% | – |
Q2 2022 | $10,000 | -98.4% | 1,064 | -97.5% | 0.00% | – |
Q1 2022 | $634,000 | -10.5% | 42,993 | -19.7% | 0.00% | – |
Q4 2021 | $708,000 | +22.1% | 53,563 | +61.2% | 0.00% | – |
Q3 2021 | $580,000 | +457.7% | 33,228 | +668.8% | 0.00% | – |
Q2 2021 | $104,000 | -62.5% | 4,322 | -59.9% | 0.00% | – |
Q1 2021 | $277,000 | +714.7% | 10,776 | +509.2% | 0.00% | – |
Q4 2020 | $34,000 | +240.0% | 1,769 | +133.4% | 0.00% | – |
Q3 2020 | $10,000 | -80.8% | 758 | -82.4% | 0.00% | – |
Q2 2020 | $52,000 | -8.8% | 4,315 | -42.6% | 0.00% | – |
Q1 2020 | $57,000 | -81.6% | 7,511 | -56.8% | 0.00% | – |
Q4 2019 | $310,000 | +150.0% | 17,393 | +62.4% | 0.00% | – |
Q3 2019 | $124,000 | +163.8% | 10,711 | +408.6% | 0.00% | – |
Q2 2019 | $47,000 | +235.7% | 2,106 | +334.2% | 0.00% | – |
Q1 2019 | $14,000 | 0.0% | 485 | -26.5% | 0.00% | – |
Q3 2018 | $14,000 | -44.0% | 660 | -78.8% | 0.00% | – |
Q2 2018 | $25,000 | +2400.0% | 3,114 | +2047.6% | 0.00% | – |
Q1 2018 | $1,000 | -93.8% | 145 | -90.9% | 0.00% | – |
Q4 2017 | $16,000 | +45.5% | 1,591 | +5.6% | 0.00% | – |
Q2 2017 | $11,000 | -38.9% | 1,506 | -34.7% | 0.00% | – |
Q1 2017 | $18,000 | +200.0% | 2,307 | +153.8% | 0.00% | – |
Q4 2016 | $6,000 | – | 909 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |